A randomized, double‐blind, single‐dose study to assess bioequivalence of MB02 biosimilar after manufacturing iteration and reference bevacizumab

Abstract To investigate and compare the pharmacokinetic (PK) profiles of MB02 products, before and after optimizing the manufacturing process, and reference bevacizumab to establish bioequivalence between them. In this randomized, double‐blind, single dose, parallel study, 114 healthy male volunteer...

ver descrição completa

Detalhes bibliográficos

Principais autores:	C. Schwabe, A. Cole, A. Espigares‐Correa, M. E. Beydon, A. Florez‐Igual, J. Queiruga‐Parada
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2023-04-01
coleção:	Pharmacology Research & Perspectives
Assuntos:	bevacizumab biosimilar clinical trial MB02 pharmacokinetics safety
Acesso em linha:	https://doi.org/10.1002/prp2.1070
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!